Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

BACKGROUND: In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incid...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mil Med Res
Autori principali: Zhao, Xin, Yang, Xiao-Xu, Ji, Su-Zhen, Wang, Xiao-Zeng, Wang, Li, Gu, Chong-Huai, Ren, Li-Li, Han, Ya-Ling
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847352/
https://ncbi.nlm.nih.gov/pubmed/27123313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40779-016-0081-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi